Showing results (21-30 of 80) with videos related to
Sort By:
Pageof 8
Frontiers in Medicine|March 26, 2021
Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-AnalysisJohannes Gratz, Marion Wiegele, Mathias Maleczek, et al.European Journal of Haematology|May 10, 2016
In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemiaKlaus Geissler, Eva Jäger, Agnes Barna, et al.Blood|July 12, 2003
Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpuraFriedrich Scheiflinger, Paul Knöbl, Bettina Trattner, et al.Thrombosis Research|August 19, 2007
Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphismSimon Panzer, Sergio Rosales, Heinz Gisslinger, et al.Transfusion|June 23, 2009
Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpuraPaul Knöbl, Bernd Jilma, James C Gilbert, et al.Thrombosis and Haemostasis|December 22, 2010
Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpuraPetra Jilma-Stohlawetz, Monika E Gorczyca, Bernd Jilma, et al.Clinical Pharmacology and Therapeutics|May 16, 2002
Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humansUrsula Hollenstein, Monika Homoncik, Paul Knöbl, et al.Thrombosis Research|December 1, 2015
Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependentPetra Jilma-Stohlawetz, Peter Quehenberger, Heinrich Schima, et al.Thrombosis Research|November 30, 2004
Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosisSophie Ziegler, Wolfgang R Sperr, Paul Knöbl, et al.Blood|April 9, 2020
Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01/2010 studyKatharina Holstein, Xiaofei Liu, Andrea Smith, et al.Pageof 8